Monday, November 28, 2022

Good Samaritan Medical Center Brings New Technology and Services to the Newly Redesigned Norma E. & Miles M. Zisson Comprehensive Breast Center of the Palm Beaches

Good Samaritan Medical Center part of the Palm Beach Health Network, has announced a new look and new equipment in the redesigned Norma E. & Miles M. Zisson Comprehensive Breast Center of the Palm Beaches.

The Palm Beach Health Network invested nearly a quarter of a million dollars into the center, bringing a sleek and calm aesthetic look, along with some of the newest high-end technology for patients being treated for their breast health.

“As we continue to change the way we treat breast cancer, it is important we continue to keep up with the latest and newest technology, so the residents of Palm Beach County can benefit from getting the very best treatments for their overall breast health,” said Sheri Montgomery, chief executive officer for Good Samaritan Medical Center. “As we have done for over 100 years, our newly redesigned center will continue to provide amazing quality care to the South Florida community.”

Some of the new additions to the center include:

  • The Genius 3D Mammography™ exam with Hologic Clarity HD – This technology generates images of the breast that are sharper and even more detailed so a cancer can be detected earlier, when it is easier to treat. It also cuts down on unnecessary follow-up appointments by up to 40% compared to 2D imaging alone. It also produces images quicker so less time for the patient to have their breast under compression
  • Affirm Breast Biopsy Guidance System – This system allows doctors to quickly perform 3D breast biopsies on patients and accurately target regions of interest for a breast biopsy assisting in breast cancer detection.
  • Supersonic Mach 40 Ultrasound – The Ultrasound system gives the highest resolution images of patients to enhance diagnostic certainty, regardless of tissue density.

“We feel confident that by offering these new technological capabilities it will ensure greater patient care and confidence for those who come in for their yearly mammograms,” said Dr. Elena Rehl, breast surgeon on staff at Good Samaritan Medical Center. “It is so important not to delay care, especially for your annual mammogram.  If you have been putting it off, we encourage you to make an appointment today.”

The Norma E. & Miles M. Zisson Comprehensive Breast Center of the Palm Beaches brings together a multi-disciplinary team of cancer specialists and allied health professionals, advanced technology and cancer resources so patients and their families may receive a comprehensive diagnosis, treatment and support services.  Call 561-650-6441 or visit www.goodsamaritanmc.com.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Must Read

Momentis Announces First Adoption of Anovo™ Surgical System in Texas by Medical City Plano

Dvir Cohen, CEO and Co-Founder of Momentis. “In the months ahead, we will continue our efforts to broaden availability of the system and improve gynecological surgery to enable more surgeons to perform the clinically preferred transvaginal approach, setting a higher standard in women’s healthcare.”

Momentis Announces HCA Oviedo Medical Center Acquires Anovo Surgical System

The Anovo Surgical System is the first and only FDA-authorized surgical robot with features including shoulder, elbow, and wrist joints designed to mimic human arms and provide human level dexterity.

Cordis Announces Acquisition of MedAlliance

By acquiring MedAlliance, Cordis has the potential to serve two million patients globally by 2027 with the SELUTION SLR™ (Sustained Limus Release) drug-eluting balloon.

By using this website you agree to accept Medical Device News Magazine Privacy Policy